Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 10, 2012, Pages 1320-1325

  Denholm, Justin T ^a,b   Leslie, D E ^c   Jenkin, G A ^d   Darby, J ^e   Johnson, P D R ^f   Graham, S M ^b,g   Brown, G V ^b   Sievers, A ^c   Globan, M ^c   Brown, L K ^h   McBryde, E S ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f AUSTIN HEALTH   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h Department of Health Victoria   (Australia)

Author keywords

Contact tracing; Drug resistant; Public health; Tuberculosis

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANALYTICAL PARAMETERS; ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CHILD; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTACT EXAMINATION; CONTROLLED STUDY; DRUG SENSITIVITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NONHUMAN; PERSON YEARS OF OBSERVATION; POST EXERCISE HYPOTENSION; PRIORITY JOURNAL; PRURITUS; RISK ASSESSMENT; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; CONTACT TRACING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PUBLIC HEALTH; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; VICTORIA; YOUNG ADULT;

EID: 84866453028     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0092     Document Type: Article

References (20)

1. Gandhi N R, Nunn P, Dheda K, Schaaf H S, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-1843.
2. Orenstein E W, Basu S, Shah N S, Andrews J R, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 153-161.
3. Suárez P G, Floyd K, Portocarrero J, Alarcón E, et al. Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 2002; 359: 1980-1989. (Pubitemid 34663712)
4. Törün T, Güngör G, Özmen Ï, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 1373-1377. (Pubitemid 43265148)
5. Falzon D, Jaramillo E, Schünemann H, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
6. Van Deun A, Maug A K J, Salim M A H, et al. Short, highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care 2010; 182: 684-692.
7. Gilpin C M, Simpson G, Vincent S, et al. Evidence of primary transmission of multidrug-resistant tuberculosis in the Western Province of Papua New Guinea. Med J Austr 2008; 188: 148-152.
8. Faustini A, Hall A J, Perucci C A. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158.
9. Denholm J T, McBryde E S. Management of latent tuberculosis infections in Australia and New Zealand: a review of current practice. Tuberc Res Treat 2010; 2010: 284028.
10. Supply P, Lesjean S, Savine E, et al. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol 2001; 39: 3563.
11. Frothingham R, Meeker-O'Connell W A. Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology 1998; 144: 1189.
12. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 4498.
13. Glynn J R, Whiteley J, Bifani P J, et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843.
14. Grandjean L, Crossa A, Gilman R H, et al. Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis 2011; 15: 1164-1169.
15. Vella V, Racalbuto V, Guerra R, et al. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis 2011; 15: 1170-1175.
16. McPherson M E, Kelly H, Patel M S, Leslie D. Persistent risk of tuberculosis in migrants a decade after arrival in Australia. Med J Aust 2008; 188: 528-531.
17. Attamna A, Chemtob D, Attamna S, et al. Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort. Thorax 2009; 64: 271.
18. Burgos M, DeRiemer K, Small P, et al. Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis 2003; 188: 1878-1884. (Pubitemid 38064874)
19. Diel R, Nienhaus A, Lange C, et al. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7: 77.
20. Centers for Disease Control and Prevention. Two simultaneous outbreaks of multidrug-resistant tuberculosis - Federated States of Micronesia, 2007-2009. MMWR Morb Mortal Wkly Rep 2009; 58: 253-256.